HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.

Abstract
Adult T-cell leukemia/lymphoma (ATLL) and cutaneous T-cell lymphomas (CTCLs) are known to frequently express CC chemokine receptor 4 (CCR4). Previously, we investigated the transcriptional control of CCR4 expression in ATLL and have found that an activating protein 1 (AP1) family member, FBJ murine osteosarcoma viral oncogene homolog (FOS)-related antigen 2 (FRA2), is consistently expressed at high levels in ATLL and, together with v-JUN avian sarcoma virus 17 oncogene homolog D (JUND), up-regulates the expression of CCR4 as well as that of several proto-oncogenes such as v-MYB myeloblastosis viral oncogene homolog (MYB), murine double minute 2 homolog (MDM2), and B-cell lymphoma 6 (BCL6). Here, we examined the expression of these genes in clinical samples of CTCLs. We detected the transcripts of FRA2, JUND, CCR4, MYB, MDM2, and BCL6 at high levels in CTCL skin lesions. Except for BCL6, we confirmed protein expression of FRA2, JUND, CCR4, MYB, and MDM2 in CTCL skin lesions. Furthermore, siRNA-mediated knockdown of FRA2 or JUND suppressed cell growth and the expression of CCR4, MYB, MDM2, and BCL6 in CTCL cell lines. Our results, thus, demonstrate the presence of a common oncogenic cascade initiated by FRA2/JUND in CCR4-expressing mature T-cell malignancies such as ATLL and CTCLs.
AuthorsTakashi Nakayama, Tomonori Higuchi, Naoki Oiso, Akira Kawada, Osamu Yoshie
JournalAnticancer research (Anticancer Res) Vol. 32 Issue 4 Pg. 1367-73 (Apr 2012) ISSN: 1791-7530 [Electronic] Greece
PMID22493372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FOSL2 protein, human
  • Fos-Related Antigen-2
  • JunD protein, human
  • Proto-Oncogene Proteins c-jun
Topics
  • Female
  • Fos-Related Antigen-2 (genetics)
  • Humans
  • Lymphoma, T-Cell (genetics)
  • Male
  • Proto-Oncogene Proteins c-jun (genetics)
  • Skin Neoplasms (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: